MedTrace Logo

DESTINY TRIAL (Inspiron x Biomatrix)

NCT01856088 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2019-03-25

No results posted yet for this study

Summary

The main objective of this study is to evaluate the effectiveness of stent Inspiron ™ sirolimus-eluting and coating the abluminal biodegradable stent Biomatrix Flex ™ lesions in native coronary arteries.

Conditions

Interventions

DEVICE

Inspiron Stent

stent implantation

DEVICE

Biomatrix Flex Stent

stent implantation

Sponsors & Collaborators

  • Scitech Produtos Medicos Ltda

    lead INDUSTRY

Principal Investigators

  • Pedro Lemos · Instituto do Coração - Incor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-09-30
Completion
2019-03-21

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01856088 on ClinicalTrials.gov